Table 5 Gender-dependent adherence to hypertension criteria
From: Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study
Criteria | Adherence (%) [95% Cl] | |
|---|---|---|
| Â | Men | Women |
| Â | n=123 | n=102 |
High level of adherence to hypertension criteria | Â | Â |
• Prescribing of antihypertensive drug(s) in hypertensive diabetic patient | 100 | 100 |
• No co-prescribing of thiazide + beta blocker in treated hypertension | 100 | 100 |
• Patient diagnosed with hypertension has a treatment plan that does NOT include oral contraceptives, corticosteroids, NSAIDs, high sodium containing products, sympathomimetics, monoamine oxidase inhibitors | 96.9 [92.6-100] | 84.6* [74.8-94.5] |
• Addition of a calcium channel blocker (CCB) and/or diuretic in patients whose blood pressure remains uncontrolled with ACE-Is or ARBs | 89.7 [80.2-99.3] | 87.8 [78.6-96.9] |
• Prescribing of an ACE-I or ARB in hypertensive patient | 85.9 [74–94.5] | 87.1 [78.8-95.4] |
Low level of adherence to hypertension criteria | Â | Â |
• Achievement of blood pressure target in patients on aspirin | 34.1 [20.1-48.1] | 23.1 [6.9-39.3] |
• Patient with treated hypertension and with co-existing kidney, eye or cerebrovascular damage and/or with two or more features of MetS has achieved blood pressure control of ≤130/80 mmHg | 16.4 [7.1-25.7] | 10.2 [2.5-17.9] |